IMMU - Immunomedics, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
26.14
+0.14 (+0.54%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous close26.00
Open26.06
Bid26.01 x 200
Ask26.25 x 100
Day's range25.88 - 26.28
52-week range7.17 - 27.33
Volume1,092,387
Avg. volume2,655,895
Market cap4.717B
Beta3.70
PE ratio (TTM)N/A
EPS (TTM)-1.54
Earnings date1 Feb 2017 - 6 Feb 2017
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est36.00
Trade prices are not sourced from all markets
  • How Financially Strong Is Immunomedics Inc (NASDAQ:IMMU)?
    Simply Wall St.24 days ago

    How Financially Strong Is Immunomedics Inc (NASDAQ:IMMU)?

    Stocks with market capitalization between $2B and $10B, such as Immunomedics Inc (NASDAQ:IMMU) with a size of US$4.32b, do not attract as much attention from the investing community as doRead More...

  • Barrons.comlast month

    [$$] Immunomedics Chairman Buys $19M More in Stock

    Two weeks ago, B. Riley analyst Madhu Kumar gushed about Immunomedics, writing in a report that the biotech could have a “blockbuster cancer drug” in IMMU-132, an antibody-drug conjugate that had shown promise in disrupting “multiple solid cancers.” Kumar initiated coverage of the biotech on June 6 at Buy with a $53 price target. On Friday, Immunomedics (IMMU) Chairman Behzad Aghazadeh bought $18.5 million worth of the company’s stock through venBio Select Fund, a hedge fund where he serves as managing partner and portfolio manager. Aghazadeh bought 575,000 Immunomedics shares through the company’s public offering at $24 each, and went to the open market to buy another 200,000 shares for a better average per-share price of $23.39.

  • After-hours buzz: RH, PLAY and more
    CNBClast month

    After-hours buzz: RH, PLAY and more

    See which stocks are posting big moves after the bell on Monday.

  • Immunomedics (IMMU) Soars: Stock Adds 10.3% in Session
    Zacks2 months ago

    Immunomedics (IMMU) Soars: Stock Adds 10.3% in Session

    Immunomedics (IMMU) shares rose more than 10% in the last trading session, amid huge volumes.

  • Why Fossil Group, Companhia Siderurgica Nacional, and Immunomedics Jumped Today
    Motley Fool2 months ago

    Why Fossil Group, Companhia Siderurgica Nacional, and Immunomedics Jumped Today

    Find out which stock had the best news today.

  • Why A Tie-Up With Clovis Helped This Biotech Spike To An 18-Year High
    Investor's Business Daily2 months ago

    Why A Tie-Up With Clovis Helped This Biotech Spike To An 18-Year High

    Immunomedics popped to an 18-year high Monday after it unveiled plans for its cancer drug, including a tie-up with Clovis Oncology to test a regimen.

  • Why Data at ASCO 2018 Sent Immunomedics Shares Soaring Today
    Motley Fool2 months ago

    Why Data at ASCO 2018 Sent Immunomedics Shares Soaring Today

    It was off to the races earlier today following compelling data on Immunomedics' lead drug.

  • Immunomedics Announces Positive Phase 2 Results
    Market Realist2 months ago

    Immunomedics Announces Positive Phase 2 Results

    Today, Immunomedics (IMMU) announced positive results from a Phase 2 trial evaluating its investigational antibody drug conjugate (or ADC) sacituzumab govitecan in patients suffering from estrogen receptor-positive (or ER+)/human epidermal growth factor receptor 2-negative (or HER2-) metastatic breast cancer who have previously received at least two therapies. The investigational ADC therapy demonstrated an overall response rate of 31% in these heavily pretreated patients. Immunomedics plans to file its first biologics license application with the FDA later this month for the approval of sacituzumab govitecan for the treatment of metastatic triple-negative breast cancer (mTNBC).

  • Associated Press2 months ago

    Immunomedics: Fiscal 3Q Earnings Snapshot

    On a per-share basis, the Morris Plains, New Jersey-based company said it had a loss of 21 cents. Losses, adjusted for non-recurring costs, were 14 cents per share. The biopharmaceutical company posted ...

  • MarketWatch3 months ago

    Harry Boxer’s four biotech stocks to watch today

    Biotechnology stocks dominate our list of top charts to watch, with a uranium producer also advancing to the list. CASI Pharmaceuticals Inc.(CASI) rose 48 cents, or 7.2%, to $7.14 on 773,700 shares traded Tuesday. The move came on no news from the company, although the stock soared in early April on news that China’s Food and Drug Administration (CFDA) would convene a panel to discuss its cancer therapy, Evomela.

  • Immunomedics (IMMU) in Focus: Stock Moves 7.9% Higher
    Zacks3 months ago

    Immunomedics (IMMU) in Focus: Stock Moves 7.9% Higher

    Immunomedics (IMMU) was a big mover last session, as the company saw its shares rise nearly 8% on the day.

  • Associated Press5 months ago

    Immunomedics reports 2Q loss

    The Morris Plains, New Jersey-based company said it had a loss of 2 cents per share. Losses, adjusted for non-recurring gains, came to 19 cents per share. The biopharmaceutical company posted revenue of ...

  • Immunomedics' Data Is Good News for Seattle Genetics, Too
    Motley Fool7 months ago

    Immunomedics' Data Is Good News for Seattle Genetics, Too

    Seattle Genetics could do handsomely following positive midstage study results for Immunomedics' lead drug.

  • Why Immunomedics, Inc. Is Soaring Today
    Motley Fool7 months ago

    Why Immunomedics, Inc. Is Soaring Today

    The release of upbeat clinical data from an important phase 2 trial causes traders to cheer.

  • Options Traders Expect Huge Moves in Immunomedics (IMMU) Stock
    Zacks8 months ago

    Options Traders Expect Huge Moves in Immunomedics (IMMU) Stock

    Investors in Immunomedics (IMMU) need to pay close attention to the stock based on moves in the options market lately.

  • Immunomedics (IMMU) Jumps: Stock Rises 5.4%
    Zacks8 months ago

    Immunomedics (IMMU) Jumps: Stock Rises 5.4%

    Immunomedics (IMMU) was a big mover last session, as the company saw its shares more than 5% on the day amid huge volumes.

  • Why Sears Holdings, Immunomedics, and J.C. Penney Slumped Today
    Motley Fool8 months ago

    Why Sears Holdings, Immunomedics, and J.C. Penney Slumped Today

    Find out what sent these stocks so much lower.

  • Why Immunomedics, Inc. Jumped Higher Today
    Motley Fool8 months ago

    Why Immunomedics, Inc. Jumped Higher Today

    A new CEO has the biotech's investors excited.

  • Associated Press8 months ago

    Immunomedics reports 1Q loss

    On a per-share basis, the Morris Plains, New Jersey-based company said it had a loss of 97 cents. Losses, adjusted for non-recurring costs, were 16 cents per share. The results fell short of Wall Street ...

  • Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock?
    Zacks9 months ago

    Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock?

    Investors in Immunomedics (IMMU) need to pay close attention to the stock based on moves in the options market lately.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes